BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16174216)

  • 1. Positron emission tomography application for gynecologic tumors.
    Nakamoto Y; Saga T; Fujii S
    Int J Gynecol Cancer; 2005; 15(5):701-9. PubMed ID: 16174216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET and PET-CT imaging of gynecological malignancies: present role and future promise.
    Basu S; Li G; Alavi A
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):75-96. PubMed ID: 19105709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
    Kitajima K; Ebina Y; Sugimura K
    Jpn J Radiol; 2014 Jun; 32(6):313-23. PubMed ID: 24744135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.
    Oldan JD; Patel PS
    Obstet Gynecol Surv; 2016 Sep; 71(9):545-56. PubMed ID: 27640609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in gynecological malignancies.
    Kumar R; Chauhan A; Jana S; Dadparvar S
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1033-44. PubMed ID: 16831075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT and radiotherapy in gynecological cancer.
    Caroli P; Fanti S
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):533-42. PubMed ID: 20927020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography imaging for gynecologic malignancy.
    Lai CH; Yen TC; Chang TC
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):37-41. PubMed ID: 17218850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Role of PET Agents Beyond FDG in Gynecology.
    Ponisio MR; Dehdashti F
    Semin Nucl Med; 2019 Nov; 49(6):501-511. PubMed ID: 31630734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-
    Kalshetty A; Basu S
    PET Clin; 2018 Apr; 13(2):239-248. PubMed ID: 29482752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MR Imaging in Gynecologic Oncology.
    Ohliger MA; Hope TA; Chapman JS; Chen LM; Behr SC; Poder L
    Magn Reson Imaging Clin N Am; 2017 Aug; 25(3):667-684. PubMed ID: 28668166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of PET Imaging in Gynecologic Radiation Oncology.
    Rao YJ; Grigsby PW
    PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.
    Allahqoli L; Hakimi S; Laganà AS; Momenimovahed Z; Mazidimoradi A; Rahmani A; Fallahi A; Salehiniya H; Ghiasvand MM; Alkatout I
    J Imaging; 2023 Oct; 9(10):. PubMed ID: 37888330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PET/CT in gynecological tumors based on the revised FIGO staging classification.
    Tsujikawa T; Tsuchida T; Yoshida Y; Kurokawa T; Kiyono Y; Okazawa H; Kimura H
    Clin Nucl Med; 2011 Sep; 36(9):e114-8. PubMed ID: 21825837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
    Pelosi E; Deandreis D
    Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.